Optimizing CML Management: Shared Decision Making and Enhancing the Patient Experience - Episode 7

CML Treatment: Scenarios that Necessitate Switching Therapy

August 21, 2024
Jorge E. Cortes, MD

,
Joannie Clements

,
Claire Saxton

Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following:

  • In which scenarios do you consider switching CML therapies, and how do you approach that conversation with patients? How does the patient experience change when switching therapies?